Anson Funds Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-855,440
Closed -$701K 102
2020
Q1
$701K Buy
+855,440
New +$933K 0.29% 51

Other funds holding NTRP

Anson Funds Management's NTRP Position: Q2 2020 in Review

Anson Funds Management sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 855,440 shares — an estimated $701K sold.

Anson Funds Management first reported a position in NTRP in Q1 2020 and held it in 1 quarter. The position peaked at $701K in Q1 2020. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Anson Funds Management reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Anson Funds Management sold 855,440 Neurotrope, Inc. Common shares in Q2 2020, an estimated $701K.
  • Anson Funds Management first reported a position in Neurotrope, Inc. Common in Q1 2020 and held it in 1 quarter.
  • Anson Funds Management's Neurotrope, Inc. Common position peaked at $701K in Q1 2020.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Anson Funds Management's 13F filing for Q2 2020, filed 12 Aug 2020.